Neuregulin-1 accelerates corneal epithelial wound healing

Area of Science:

• Ophthalmology
• Regenerative Medicine
• Cell Biology

Background:

• Corneal epithelial cells (CECs) are vital for corneal function and are maintained by corneal epithelial stem cells (CESCs).
• Neuronal growth factors influence CESC proliferation and migration, suggesting a role in corneal repair.

Purpose of the Study:

• To investigate the potential of Neuregulin-1 (NR-1), a neuronal growth factor, in activating and accelerating corneal wound healing.

Main Methods:

• Assessed NR-1's effects on CEC proliferation and migration in vitro.
• Evaluated NR-1's impact on CESC colony-forming efficacy.
• Administered NR-1 treatment to mice with corneal wounds and analyzed healing outcomes.
• Measured expression of key markers (ΔNp63, Bmi-1, Abcg2) and intracellular signaling pathways (Stat3, Erk1/2, p38).

Main Results:

• NR-1 treatment significantly enhanced CEC proliferation and migration.
• Colony-forming efficacy of CESCs was notably improved by NR-1.
• In vivo studies demonstrated accelerated corneal wound healing in NR-1 treated mice.
• NR-1 upregulated corneal epithelium maintenance and CESC proliferation markers, mediated by Stat3, Erk1/2, and p38 pathways.

Conclusions:

• Neuregulin-1 (NR-1) effectively promotes corneal epithelial cell and stem cell activity.
• NR-1 accelerates corneal wound healing in a mouse model.
• NR-1 shows promise as a novel therapeutic agent for treating corneal damage.